BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kowalski RJ, Post DR, Mannon RB, Sebastian A, Wright HI, Sigle G, Burdick J, Elmagd KA, Zeevi A, Lopez-Cepero M, Daller JA, Gritsch HA, Reed EF, Jonsson J, Hawkins D, Britz JA. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation. 2006;82:663-668. [PMID: 16969290 DOI: 10.1097/01.tp.0000234837.02126.70] [Cited by in Crossref: 258] [Cited by in F6Publishing: 228] [Article Influence: 16.1] [Reference Citation Analysis]
Number Citing Articles
1 Te HS. Recurrent hepatitis C: the bane of transplant hepatology. Hepatology 2014;59:21-3. [PMID: 23813788 DOI: 10.1002/hep.26591] [Reference Citation Analysis]
2 Yu Y, Feng S, Wei S, Zhong Y, Yi G, Chen H, Liang L, Chen H, Lu X. Extracellular ATP activates P2X7R-NF-κB (p65) pathway to promote the maturation of bone marrow-derived dendritic cells of mice. Cytokine 2019;119:175-81. [PMID: 30952064 DOI: 10.1016/j.cyto.2019.03.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Visner GA, Goldfarb SB. Posttransplant monitoring of pediatric lung transplant recipients. Current Opinion in Pediatrics 2007;19:321-6. [DOI: 10.1097/mop.0b013e3280991205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Torío A, Fernández EJ, Montes-Ares O, Guerra RM, Pérez MA, Checa MD. Lack of association of immune cell function test with rejection in kidney transplantation. Transplant Proc 2011;43:2168-70. [PMID: 21839223 DOI: 10.1016/j.transproceed.2011.06.056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gurevich M, Levi I, Steinberg R, Shonfeld T, Shapiro R, Israeli M, Sprecher H, Shalit I, Mor E. Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management. Transpl Infect Dis 2012;14:E97-E101. [DOI: 10.1111/j.1399-3062.2012.00776.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
6 Dharnidharka VR, Malone A. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol 2018;33:1113-22. [PMID: 28631040 DOI: 10.1007/s00467-017-3712-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
7 Sood S, Cundall D, Yu L, Miyamasu M, Boyle JS, Ong SY, Gow PJ, Jones RM, Angus PW, Visvanathan K. A novel biomarker of immune function and initial experience in a transplant population. Transplantation. 2014;97:e50-e51. [PMID: 24732902 DOI: 10.1097/tp.0000000000000078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
8 Potena L, Zuckermann A, Barberini F, Aliabadi-Zuckermann A. Complications of Cardiac Transplantation. Curr Cardiol Rep 2018;20:73. [PMID: 29992503 DOI: 10.1007/s11886-018-1018-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Fernández-Ruiz M, Parra P, Ruiz-Merlo T, López-Medrano F, San Juan R, Polanco N, González E, Andrés A, Aguado JM. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload. Transpl Infect Dis 2018;20. [PMID: 29120522 DOI: 10.1111/tid.12807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Kittleson MM, Kobashigawa JA. Long-term care of the heart transplant recipient. Current Opinion in Organ Transplantation 2014;19:515-24. [DOI: 10.1097/mot.0000000000000117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
11 Tsukada K, Sugawara Y, Kaneko J, Tamura S, Tachikawa N, Morisawa Y, Okugawa S, Kikuchi Y, Oka S, Kimura S, Yatomi Y, Makuuchi M, Kokudo N, Koike K. Living donor liver transplantations in HIV- and hepatitis C virus-coinfected hemophiliacs: experience in a single center. Transplantation 2011;91:1261-4. [PMID: 21593704 DOI: 10.1097/TP.0b013e3182193cf3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
12 Cravedi P, Mannon RB. Noninvasive methods to assess the risk of kidney transplant rejection. Expert Rev Clin Immunol 2009;5:535-46. [PMID: 20161000 DOI: 10.1586/eci.09.36] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
13 Suviolahti E, Petrosyan A, Mirocha J, Ge S, Karasyov A, Thomas D, Galera O, Lim W, Jimenez AM, Czer LS, Chaux G, De Leon J, Pao A, Jordan SC, Toyoda M. Significant reduction of ATP production in PHA-activated CD4+ cells in 1-day-old blood from transplant patients. Transplantation 2012;94:1243-9. [PMID: 23135604 DOI: 10.1097/TP.0b013e318270f322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Berastegui C, Román J, Monforte V, Bravo C, López-Meseguer M, Montero MÁ, Culebras M, Gómez-Ollés S, Román A. Biomarkers of pulmonary rejection. Transplant Proc 2013;45:3163-9. [PMID: 24182778 DOI: 10.1016/j.transproceed.2013.06.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
15 Confer B, Choudhary M, Lopez R, Zein N. Monitoring Serial CD4+ T-Cell Function After Liver Transplantation Can Be Used to Predict Hepatocellular Carcinoma Recurrence. Transplantation Proceedings 2015;47:217-22. [DOI: 10.1016/j.transproceed.2014.10.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Mizuno S, Hamada T, Nakatani K, Kishiwada M, Usui M, Sakurai H, Tabata M, Sakamoto Y, Nishioka J, Muraki Y. Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype. J Hepatobiliary Pancreat Sci. 2011;18:226-232; discussion 232-234. [PMID: 21165655 DOI: 10.1007/s00534-010-0335-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
17 Narasimhan M, Mahimainathan L, Clark AE, Usmani A, Cao J, Araj E, Torres F, Sarode R, Kaza V, Lacelle C, Muthukumar A. Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines. Vaccines (Basel) 2021;9:708. [PMID: 34208884 DOI: 10.3390/vaccines9070708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Roberts MB, Fishman JA. Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression". Clin Infect Dis 2020:ciaa1189. [PMID: 32803228 DOI: 10.1093/cid/ciaa1189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
19 Zhang W, Zhong H, Zhuang L, Yu J, Xu X, Wang W, Zhang M, Zhou L, Zheng S. Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post-DCD liver transplant. Int J Clin Pract 2016;70 Suppl 185:11-6. [PMID: 27197999 DOI: 10.1111/ijcp.12811] [Reference Citation Analysis]
20 Srivastava M, Torosyan Y, Eidelman O, Jozwik C, Pollard HB, Mannon R. Reduced PARP1 as a Serum Biomarker for Graft Rejection in Kidney Transplantation. J Proteomics Bioinform 2015;8:031-38. [PMID: 26962294 DOI: 10.4172/jpb.1000350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. The Lancet 2011;378:1428-37. [DOI: 10.1016/s0140-6736(11)60699-5] [Cited by in Crossref: 209] [Cited by in F6Publishing: 65] [Article Influence: 19.0] [Reference Citation Analysis]
22 Lee A, Jeong JC, Choi YW, Seok HY, Kim YG, Jeong KH, Moon JY, Lee TW, Ihm CG, Jeon HJ, Koo TY, Ahn C, Lim SJ, Yang J, Lee SH. Validation study of peripheral blood diagnostic test for acute rejection in kidney transplantation. Transplantation 2014;98:760-5. [PMID: 25208320 DOI: 10.1097/TP.0000000000000138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
23 Shino MY, Weigt SS, Saggar R, Elashoff D, Derhovanessian A, Gregson AL, Saggar R, Reed EF, Kubak BM, Lynch JP 3rd, Belperio JA, Ardehali A, Ross DJ. Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes. J Heart Lung Transplant 2012;31:996-1002. [PMID: 22884386 DOI: 10.1016/j.healun.2012.05.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
24 Israeli M, Klein T, Brandhorst G, Oellerich M. Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay. Clin Chim Acta. 2012;413:1374-1378. [PMID: 22333671 DOI: 10.1016/j.cca.2012.01.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
25 Hokari M, Nakayama N, Kazumata K, Osanai T, Shichinohe H, Abumiya T, Houkin K. Surgical Outcome of Cerebral Aneurysm Clipping Treated with Immunosuppressants: Report of 11 Cases and Review of the Literature. Neurol Med Chir (Tokyo) 2017;57:122-7. [PMID: 28154343 DOI: 10.2176/nmc.oa.2016-0185] [Reference Citation Analysis]
26 Cheng JW, Shi YH, Fan J, Huang XW, Qiu SJ, Xiao YS, Wang Z, Dai Z, Tang ZY, Zhou J. An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2011;137:1445-1453. [PMID: 21809031 DOI: 10.1007/s00432-011-1014-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
27 Levitsky J. Next level of immunosuppression: drug/immune monitoring. Liver Transpl. 2011;17 Suppl 3:S60-S65. [PMID: 21761551 DOI: 10.1002/lt.22385] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
28 Coiffard B, Piloni D, Boucekine M, Morosini M, Meloni F, Kessler R, Reynaud-Gaubert M. Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study. Transpl Immunol 2018;48:47-54. [PMID: 29475091 DOI: 10.1016/j.trim.2018.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Zarrinpar A, Hong JC. What is the prognosis after retransplantation of the liver? Adv Surg. 2012;46:87-100. [PMID: 22873034 DOI: 10.1016/j.yasu.2012.03.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
30 Hwang S, Kim KH, Song GW, Yu YD, Park GC, Kim KW, Choi NK, Park PJ, Choi YI, Jung DH. Peritransplant monitoring of immune cell function in adult living donor liver transplantation. Transplant Proc. 2010;42:2567-2571. [PMID: 20832545 DOI: 10.1016/j.transproceed.2010.04.040] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008;27:990-4. [PMID: 18765191 DOI: 10.1016/j.healun.2008.06.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
32 Tinckam K. Histocompatibility methods. Transplantation Reviews 2009;23:80-93. [DOI: 10.1016/j.trre.2009.01.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
33 Stratta RJ, Pietrangeli C, Baillie GM. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Pharmacotherapy. 2010;30:144-157. [PMID: 20099989 DOI: 10.1592/phco.30.2.144] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
34 Weston MW, Rinde-Hoffman D, Lopez-Cepero M. Monitoring cell-mediated immunity during immunosuppression reduction in heart transplant recipients with severe systemic infections. Clin Transplant 2020;34:e13809. [PMID: 32003048 DOI: 10.1111/ctr.13809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Levy GA. Progress in Transplantation. Therapeutic Drug Monitoring 2010;32:246-9. [DOI: 10.1097/ftd.0b013e3181dca981] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
36 Batal I, Franco ZM, Shapiro R, Basu A, Tan H, Kayler L, Zeevi A, Morgan C, Randhawa P. Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Human Pathology 2009;40:1312-9. [DOI: 10.1016/j.humpath.2009.01.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
37 Jha V. Post-transplant infections: An ounce of prevention. Indian J Nephrol. 2010;20:171-178. [PMID: 21206677 DOI: 10.4103/0971-4065.73431] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
38 Wang Z, Liu X, Lu P, Han Z, Tao J, Wang J, Liu K, Wu B, Yin C, Tan R, Gu M. Performance of the ImmuKnow Assay in Differentiating Infection and Acute Rejection After Kidney Transplantation: A Meta-Analysis. Transplantation Proceedings 2014;46:3343-51. [DOI: 10.1016/j.transproceed.2014.09.109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
39 Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl. 2008;14:1313-1322. [PMID: 18756485 DOI: 10.1002/lt.21529] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
40 Kobayashi S, Soyama A, Takatsuki M, Hidaka M, Adachi T, Kitasato A, Kinoshita A, Hara T, Kanetaka K, Fujita F, Kuroki T, Eguchi S. Relationship between immune function recovery and infectious complications in patients following living donor liver transplantation: Recipient immune function recovery after LDLT. Hepatol Res 2016;46:908-15. [DOI: 10.1111/hepr.12635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
41 Pérez-Flores I, Sánchez-Fructuoso A, Santiago JL, Fernández-Arquero M, Calvo N, de la Concha EG, Barrientos A. Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. Transplant Proc 2009;41:2106-8. [PMID: 19715845 DOI: 10.1016/j.transproceed.2009.06.136] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
42 Brandt C, Liman P, Bendfeldt H, Mueller K, Reinke P, Radbruch A, Worm M, Baumgrass R. Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells. Cytometry A 2010;77:607-13. [PMID: 20583270 DOI: 10.1002/cyto.a.20928] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
43 Nagarajan V, Hernandez AV, Cauthen CA, Starling RC, Tang WH. Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure. Am Heart J 2017;183:35-9. [PMID: 27979039 DOI: 10.1016/j.ahj.2016.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Abboudi H, Macphee IA. Individualized immunosuppression in transplant patients: potential role of pharmacogenetics. Pharmgenomics Pers Med 2012;5:63-72. [PMID: 23226063 DOI: 10.2147/PGPM.S21743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
46 De Paolis P, Favarò A, Piola A, Martini F, Cristiana G, Agrati C, Iappelli M, Di Giulio S. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. Transplant Proc 2011;43:1013-6. [PMID: 21620039 DOI: 10.1016/j.transproceed.2011.02.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
47 Reinsmoen NL, Cornett KM, Kloehn R, Burnette AD, McHugh L, Flewellen BK, Matas A, Savik K. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation 2008;85:462-70. [PMID: 18301338 DOI: 10.1097/TP.0b013e3181612ead] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
48 Sigdel TK, Sarwal MM. Recent advances in biomarker discovery in solid organ transplant by proteomics. Expert Rev Proteomics 2011;8:705-15. [PMID: 22087656 DOI: 10.1586/epr.11.66] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
49 Fan H, Cao P, Game DS, Dazzi F, Liu Z, Jiang S. Regulatory T cell therapy for the induction of clinical organ transplantation tolerance. Semin Immunol 2011;23:453-61. [PMID: 21920772 DOI: 10.1016/j.smim.2011.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
50 Sigdel TK, Gao X, Sarwal MM. Protein and peptide biomarkers in organ transplantation. Biomark Med 2012;6:259-71. [PMID: 22731899 DOI: 10.2217/bmm.12.29] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
51 Qu W, Zhu ZJ, Sun LY, Wei L, Liu Y, Zeng ZG. Correlation Between Survival Interval and CD4+ T-Cell Intracellular ATP Levels in Liver Transplant Recipients. Transplant Proc 2017;49:316-21. [PMID: 28219591 DOI: 10.1016/j.transproceed.2016.11.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Fernández-Ruiz M, Kumar D, Humar A. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clin Transl Immunology. 2014;3:e12. [PMID: 25505960 DOI: 10.1038/cti.2014.3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 10.5] [Reference Citation Analysis]
53 Alonso-Arias R, Suárez-Alvarez B, López-Vázquez A, Moro MA, Baltar J, Gómez-Huertas E, Ortega T, Ortega F, López-Larrea C. CD127(low) expression in CD4+CD25(high) T cells as immune biomarker of renal function in transplant patients. Transplantation 2009;88:S85-93. [PMID: 19667968 DOI: 10.1097/TP.0b013e3181afebdb] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
54 Wiesner RH, Fung JJ. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 2011;17 Suppl 3:S1-S9. [PMID: 21850697 DOI: 10.1002/lt.22410] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
55 Crespo-Leiro MG, Barge-Caballero E, Marzoa-Rivas R, Paniagua-Martin MJ. Heart transplantation. Curr Opin Organ Transplant 2010;15:633-8. [PMID: 20720492 DOI: 10.1097/MOT.0b013e32833deb03] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Girardot T, Mouillaux J, Idealisoa E, Poujol F, Rouget C, Rimmelé T, Monneret G, Textoris J, Venet F. An optimized protocol for adenosine triphosphate quantification in T lymphocytes of lymphopenic patients. J Immunol Methods 2016;439:59-66. [PMID: 27720850 DOI: 10.1016/j.jim.2016.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Wang XZ, Jin ZK, Tian XH, Xue WJ, Tian PX, Ding XM, Zheng J, Li Y, Jing X, Luo ZZ. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients. Transpl Immunol 2014;30:18-23. [PMID: 24211610 DOI: 10.1016/j.trim.2013.10.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
58 Dendle C, Mulley WR, Holdsworth S. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Transplant Rev (Orlando) 2019;33:87-98. [PMID: 30551846 DOI: 10.1016/j.trre.2018.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
59 Hellström VC, Enström Y, von Zur-mühlen B, Hagberg H, Laurell A, Nyberg F, Bäckman L, Opelz G, Döhler B, Holmberg L, Tufveson G, Enblad G, Lorant T. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study. Acta Oncologica 2016;55:774-81. [DOI: 10.3109/0284186x.2015.1130855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sicard A, Kanitakis J, Dubois V, Petruzzo P, Badet L, Thaunat O, Morelon E. An integrated view of immune monitoring in vascularized composite allotransplantation. Curr Opin Organ Transplant 2016;21:516-22. [PMID: 27517506 DOI: 10.1097/MOT.0000000000000354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
61 Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplantation 2013;17:133-43. [DOI: 10.1111/petr.12022] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
62 Millán O, Urtasun N, Brunet M. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients. Transplantation Reviews 2009;23:120-8. [DOI: 10.1016/j.trre.2009.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
63 Laporta Hernández R, Lázaro Carrasco MT, Varela de Ugarte A, Ussetti Gil P. Long-Term Follow-Up of the Lung Transplant Patient. Archivos de Bronconeumología (English Edition) 2014;50:67-72. [DOI: 10.1016/j.arbr.2014.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Patel JK, Kobashigawa JA. Thoracic Organ Transplantation: Laboratory Methods. In: Zachary AA, Leffell MS, editors. Transplantation Immunology. Totowa: Humana Press; 2013. pp. 127-43. [DOI: 10.1007/978-1-62703-493-7_7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
65 Quaglia M, Cena T, Fenoglio R, Musetti C, Cagna D, Radin E, Roggero S, Amoroso A, Magnani C, Stratta P. Immune Function Assay (Immunknow) Drop Over First 6 Months After Renal Transplant: A Predictor of Opportunistic Viral Infections? Transplantation Proceedings 2014;46:2220-3. [DOI: 10.1016/j.transproceed.2014.07.050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
66 Haddad F, Deuse T, Pham M, Khazanie P, Rosso F, Luikart H, Valantine H, Leon S, Vu TA, Hunt SA. Changing trends in infectious disease in heart transplantation. J Heart Lung Transplant. 2010;29:306-315. [PMID: 19853478 DOI: 10.1016/j.healun.2009.08.018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
67 Lacotte S, Berney T, Shapiro AJ, Toso C. Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events. Expert Opin Biol Ther 2011;11:55-66. [PMID: 21073277 DOI: 10.1517/14712598.2011.536530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
68 Vittoraki AG, Boletis JN, Darema MN, Kostakis AJ, Iniotaki AG. Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipients. Transplant Proc 2014;46:108-14. [PMID: 24507034 DOI: 10.1016/j.transproceed.2013.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc. 2009;6:54-65. [PMID: 19131531 DOI: 10.1513/pats.200808-080go] [Cited by in Crossref: 99] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
70 Fleming JN, Weimert NA. Novel strategies for immune monitoring in kidney transplant recipients. Adv Chronic Kidney Dis 2010;17:e63-77. [PMID: 20727505 DOI: 10.1053/j.ackd.2010.05.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
71 Piloni D, Magni S, Oggionni T, Benazzo A, Stella G, Scudeller L, Morosini M, Cova E, Meloni F. Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients. Transpl Immunol 2016;37:35-9. [PMID: 27095000 DOI: 10.1016/j.trim.2016.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
72 Choudhary NS, Saigal S, Shukla R, Kotecha H, Saraf N, Soin AS. Current status of immunosuppression in liver transplantation. J Clin Exp Hepatol 2013;3:150-8. [PMID: 25755489 DOI: 10.1016/j.jceh.2013.04.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
73 Millán O, Rafael-Valdivia L, Torrademé E, López A, Fortuna V, Sánchez-Cabus S, López-Púa Y, Rimola A, Brunet M. Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients. Cytokine. 2013;61:556-564. [PMID: 23265966 DOI: 10.1016/j.cyto.2012.10.026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
74 Jacquemont L, Soulillou JP, Degauque N. Blood biomarkers of kidney transplant rejection, an endless search? Expert Rev Mol Diagn 2017;17:687-97. [PMID: 28571481 DOI: 10.1080/14737159.2017.1337512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Trop-steinberg S, Azar Y, Bringer R, Or R. Myc and AP-1 expression in T cells and T-cell activation in patients after hematopoietic stem cell transplantation. Clin Exp Med 2015;15:189-203. [DOI: 10.1007/s10238-014-0285-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Castellaneta A, Thomson AW, Nayyar N, de Vera M, Mazariegos GV. Monitoring the operationally tolerant liver allograft recipient. Curr Opin Organ Transplant. 2010;15:28-34. [PMID: 19890211 DOI: 10.1097/mot.0b013e328334269a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
77 Dong JY, Yin H, Li RD, Ding GS, Fu ZR, Wu YM, Wang ZX. The relationship between adenosine triphosphate within CD4(+) T lymphocytes and acute rejection after liver transplantation. Clin Transplant 2011;25:E292-6. [PMID: 21470308 DOI: 10.1111/j.1399-0012.2011.01429.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
78 Pérez-Jacoiste Asín MA, Fernández-Ruiz M, López-Medrano F, Aquilino C, González E, Ruiz-Merlo T, Gutiérrez E, San Juan R, Paz-Artal E, Andrés A, Aguado JM. Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients. Transpl Int 2016;29:1094-105. [PMID: 27362817 DOI: 10.1111/tri.12816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
79 Barraclough KA, Staatz CE, Isbel NM, McTaggart SJ. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation. Nephrology (Carlton). 2010;15:522-532. [PMID: 20649871 DOI: 10.1111/j.1440-1797.2010.01349.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
80 Ben Gal T, Israeli M, Yaari V, Hasdai D, Matz I, Yussim A, Battler A, Klein T, Medalion B. Utility of immune monitoring in heart transplant recipients on everolimus-based immune suppression. Clin Transplant 2014;28:428-33. [DOI: 10.1111/ctr.12331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
81 Zhou H, Lin J, Chen S, Ma L, Qiu Z, Chen W, Zhang X, Zhang Y, Lin X. Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation. Clin Exp Nephrol 2013;17:304-9. [PMID: 23053591 DOI: 10.1007/s10157-012-0688-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
82 Sommerer C, Giese T, Meuer S, Zeier M. Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit? Nephrol Dial Transplant. 2009;24:21-27. [PMID: 18842676 DOI: 10.1093/ndt/gfn556] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
83 Wong MS, Boucek R, Kemna M, Rutledge J, Law Y. Immune cell function assay in pediatric heart transplant recipients. Pediatr Transplant 2014;18:485-90. [PMID: 24930882 DOI: 10.1111/petr.12298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Townamchai N, Safa K, Chandraker A. Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract 2013;32:52-61. [PMID: 26877913 DOI: 10.1016/j.krcp.2013.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
85 Ryan CM, Chaudhuri A, Concepcion W, Grimm PC. Immune cell function assay does not identify biopsy-proven pediatric renal allograft rejection or infection. Pediatr Transplant 2014;18:446-52. [PMID: 24930482 DOI: 10.1111/petr.12295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
86 Jain N, Liu H, Artz AS, Anastasi J, Odenike O, Godley LA, Joseph L, Marino S, Kline J, Nguyen V, Schouten V, Kunnavakkam R, Larson RA, Stock W, Ulaszek J, Savage PA, Wickrema A, van Besien K. Immune reconstitution after combined haploidentical and umbilical cord blood transplant. Leuk Lymphoma 2013;54:1242-9. [PMID: 23088744 DOI: 10.3109/10428194.2012.739688] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
87 San Segundo D, Fernández-Fresnedo G, Gago M, Beares I, Ruiz-Criado J, González M, Ruiz JC, Gómez-Alamillo C, Arias M, López-Hoyos M. Number of peripheral blood regulatory T cells and lymphocyte activation at 3 months after conversion to mTOR inhibitor therapy. Transplant Proc 2010;42:2871-3. [PMID: 20970555 DOI: 10.1016/j.transproceed.2010.07.045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
88 Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, O'Neill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW; CHOICE investigators. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurol 2010;9:381-90. [PMID: 20163990 DOI: 10.1016/S1474-4422(10)70033-8] [Cited by in Crossref: 226] [Cited by in F6Publishing: 86] [Article Influence: 18.8] [Reference Citation Analysis]
89 Sánchez-Velasco P, Rodrigo E, Valero R, Ruiz JC, Fernández-Fresnedo G, López-Hoyos M, Piñera C, Palomar R, Leyva-Cobián F, Arias M. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection. Clin Transplant 2008;22:55-60. [PMID: 18217906 DOI: 10.1111/j.1399-0012.2007.00744.x] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
90 Zhang QQ, Xie YL, Zhang WJ, Wang F, Luo Y, Chen S, Chang S. Lymphocyte function based on IFN-γ secretion assay may be a promising indicator for assessing different immune status in renal transplant recipients. Clin Chim Acta 2021;523:247-59. [PMID: 34626603 DOI: 10.1016/j.cca.2021.10.003] [Reference Citation Analysis]
91 Akhlaghi F, Gohh RY. The level of ATP production in mitogen-stimulated CD4+ lymphocytes is independent of the time of ingestion of immunosuppressive agents. Ther Drug Monit 2010;32:116-7. [PMID: 20104140 DOI: 10.1097/FTD.0b013e3181c324df] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
92 Serban G, Whittaker V, Fan J, Liu Z, Manga K, Khan M, Kontogianni K, Padmanabhan A, Cohen D, Suciu-Foca N, Ratner L, Colovai AI. Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. Hum Immunol 2009;70:882-90. [PMID: 19664673 DOI: 10.1016/j.humimm.2009.07.027] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
93 Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med. 2011;32:295-310. [PMID: 21511091 DOI: 10.1016/j.ccm.2011.02.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
94 Sudan DL. Treatment of intestinal failure: intestinal transplantation. Nat Clin Pract Gastroenterol Hepatol 2007;4:503-10. [PMID: 17768395 DOI: 10.1038/ncpgasthep0901] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
95 Natsuda K, Soyama A, Takatsuki M, Hidaka M, Kitasato A, Adachi T, Kuroki T, Eguchi S. The efficacy of the ImmuKnow assay for evaluating the immune status in human immunodeficiency virus and hepatitis C virus-coinfected patients. Transplant Proc 2014;46:733-5. [PMID: 24767336 DOI: 10.1016/j.transproceed.2013.11.119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Esquivel CO, Benden C. Clinical models of tolerance induction in pediatric transplantation. Pediatr Transplant 2009;13:397-9. [PMID: 19032421 DOI: 10.1111/j.1399-3046.2008.01082.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
97 Safa K, Magee CN, Azzi J. A critical review of biomarkers in kidney transplantation: . Current Opinion in Nephrology and Hypertension 2017;26:509-15. [DOI: 10.1097/mnh.0000000000000361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Mrzljak A, Vilibic-Cavlek T. Torque teno virus in liver diseases and after liver transplantation. World J Transplant 2020; 10(11): 291-296 [PMID: 33312890 DOI: 10.5500/wjt.v10.i11.291] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Hill MC, Belkin MN, McMullen P 2nd, Pillarella JJ, Macaluso GP, Treitman AN, Pappas PS, Tatooles AJ, Cotts WG, Andrade AA, Kim G, Narang N. Management of Pulmonary Mucormycosis After Orthotopic Heart Transplant: A Case Series. Transplant Proc 2021:S0041-1345(21)00733-8. [PMID: 34772489 DOI: 10.1016/j.transproceed.2021.09.034] [Reference Citation Analysis]
100 Zitzner JR, Tambur AR. Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation. Cells 2012;1:100-10. [PMID: 24710417 DOI: 10.3390/cells1020100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
101 Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy. Ther Drug Monit 2012;34:4-10. [PMID: 22210096 DOI: 10.1097/FTD.0b013e31823c5668] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
102 Lau AH, Turnquist HR, Tokita D, Zeevi A, Mazariegos GV, Thomson AW. “Tolerance” assays: the physician's guide to safe weaning of immunosuppression? Transplantation Reviews 2006;20:208-21. [DOI: 10.1016/j.trre.2006.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
103 Toyoda M, Thomas D, Ahn G, Kahwaji J, Mirocha J, Chu M, Vo A, Suviolahti E, Ge S, Jordan SC. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab. Transpl Infect Dis 2015;17:838-47. [PMID: 26437369 DOI: 10.1111/tid.12465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
104 Miyazaki T, Tagawa T, Yamasaki N, Tsuchiya T, Matsumoto K, Nagayasu T. Two Case Reports of Successful Withdrawal of Mycofenolate Mofetil After Living Donor Lobar Lung Transplantation. Transplantation Proceedings 2013;45:356-9. [DOI: 10.1016/j.transproceed.2012.09.112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
105 Lochmanova A, Lochman I, Tomaskova H, Marsalkova P, Raszka J, Mrazek J, Dedochova J, Martinek A, Brozmanova H. Quantiferon-CMV Test in Prediction of Cytomegalovirus Infection After Kidney Transplantation. Transplantation Proceedings 2010;42:3574-7. [DOI: 10.1016/j.transproceed.2010.07.101] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
106 Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
107 Niwa M, Miwa Y, Kuzuya T, Iwasaki K, Haneda M, Ueki T, Katayama A, Hiramitsu T, Goto N, Nagasaka T, Watarai Y, Uchida K, Nakao A, Kobayashi T. Stimulation index for PCNA mRNA in peripheral blood as immune function monitoring after renal transplantation. Transplantation 2009;87:1411-4. [PMID: 19424044 DOI: 10.1097/TP.0b013e3181a277bb] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
108 Wieland E, Olbricht CJ, Süsal C, Gurragchaa P, Böhler T, Israeli M, Sommerer C, Budde K, Hartmann B, Shipkova M. Biomarkers as a tool for management of immunosuppression in transplant patients. Ther Drug Monit. 2010;32:560-572. [PMID: 20814352 DOI: 10.1097/ftd.0b013e3181efb3d2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
109 Leshem YA, David M, Hodak E, Waitman DA, Vardy D, Israeli M, Eskin-schwartz M, Bergman R, Mimouni D. A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab. Arch Dermatol Res 2014;306:67-74. [DOI: 10.1007/s00403-013-1355-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
110 Naderi H, Pourmand G, Dehghani S, Nikoueinejad H, Jafari M, Tajik N. Monitoring cellular immune function of renal transplant recipients based on adenosine triphosphate (ATP) production by mitogen-induced CD4+ T helper cells. Biomed Pharmacother 2018;107:1402-9. [PMID: 30257356 DOI: 10.1016/j.biopha.2018.08.110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Kittleson MM, Kobashigawa JA. Management of the ACC/AHA Stage D patient: cardiac transplantation. Cardiol Clin 2014;32:95-112, viii. [PMID: 24286581 DOI: 10.1016/j.ccl.2013.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
112 Guillén D, Cofán F, Ros E, Millán O, Cofán M, Brunet M. Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients. Mol Diagn Ther 2010;14:357-66. [PMID: 21047146 DOI: 10.1007/BF03256393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
113 Naderi H, Najafi A, Khoshroo M, Tajik N. Development of an immune function assay by measuring intracellular adenosine triphosphate (iATP) levels in mitogen-stimulated CD4+ T lymphocytes. J Immunoassay Immunochem 2016;37:407-20. [PMID: 27089103 DOI: 10.1080/15321819.2016.1155995] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
114 Patel J, Kobashigawa JA. Minimization of immunosuppression. Transplant Immunology 2008;20:48-54. [DOI: 10.1016/j.trim.2008.10.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
115 Israeli M, Klein T, Sredni B, Avitzur Y, Mor E, Bar-Nathen N, Steinberg R, Dinari G, Shapiro R. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008;14:893-8. [PMID: 18508374 DOI: 10.1002/lt.21426] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
116 Muraki Y, Mizuno S, Nakatani K, Wakabayashi H, Ishikawa E, Araki T, Taniguchi A, Isaji S, Okuda M. Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases. Exp Ther Med 2018;15:532-8. [PMID: 29375701 DOI: 10.3892/etm.2017.5364] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
117 Israeli M, Yussim A, Mor E, Sredni B, Klein T. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007;18:7-12. [PMID: 17584596 DOI: 10.1016/j.trim.2007.03.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
118 Roedder S, Vitalone M, Khatri P, Sarwal MM. Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 2011;3:37. [PMID: 21658299 DOI: 10.1186/gm253] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
119 Sawitzki B, Schlickeiser S, Reinke P, Volk HD. Monitoring tolerance and rejection in organ transplant recipients. Biomarkers. 2011;16 Suppl 1:S42-S50. [PMID: 21707443 DOI: 10.3109/1354750x.2011.578754] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
120 Cheng P, Zhong L, Jiang Z, Wang Y, Pan M, Gao YI. High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation. Exp Ther Med 2015;10:1003-8. [PMID: 26622429 DOI: 10.3892/etm.2015.2608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Macedo C, Zeevi A, Bentlejewski C, Popescu I, Green M, Rowe D, Smith L, Webber S, Metes D. The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients. Transplantation 2009;88:123-8. [PMID: 19584691 DOI: 10.1097/TP.0b013e3181aacdd7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
122 Rodrigo E, López-Hoyos M, Corral M, Fábrega E, Fernández-Fresnedo G, San Segundo D, Piñera C, Arias M. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transpl 2012;18:1245-53. [PMID: 22740321 DOI: 10.1002/lt.23497] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
123 Shipkova M. Biomarker monitoring in immunosuppressant therapy. Personalized Immunosuppression in Transplantation. Elsevier; 2016. pp. 125-52. [DOI: 10.1016/b978-0-12-800885-0.00006-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 Qu W, Zhu ZJ, Sun LY, Wei L, Liu Y, Zeng ZG. Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients. Transplant Proc 2016;48:2094-7. [PMID: 27569951 DOI: 10.1016/j.transproceed.2016.03.047] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Israeli M, Ben-Gal T, Yaari V, Valdman A, Matz I, Medalion B, Battler A, Sredni B, Kristt D, Klein T. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests. Transplantation 2010;89:968-76. [PMID: 20075792 DOI: 10.1097/TP.0b013e3181cbabe6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
126 Boccard M, Albert-Vega C, Mouton W, Durieu I, Brengel-Pesce K, Venet F, Trouillet-Assant S, Ader F. [Functional immunoassays in the setting of infectious risk and immunosuppressive therapy of non-HIV immunocompromised patients]. Rev Med Interne 2020;41:545-51. [PMID: 32624260 DOI: 10.1016/j.revmed.2020.04.008] [Reference Citation Analysis]
127 Serrano M, Meneu JC, Medina E, Alfaro FJ, Martinez-Flores JA, Mora S, Morales JM, Paz Artal E, Manzanares J, Serrano A. Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. Transplant Proc 2012;44:2622-4. [PMID: 23146475 DOI: 10.1016/j.transproceed.2012.09.080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Ling X, Xiong J, Liang W, Schroder PM, Wu L, Ju W, Kong Y, Shang Y, Guo Z, He X. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation. 2012;93:737-743. [PMID: 22357178 DOI: 10.1097/tp.0b013e3182466248] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 6.4] [Reference Citation Analysis]
129 Nickel P, Bestard O, Volk H, Reinke P. Diagnostic value of T-cell monitoring assays in kidney transplantation: . Current Opinion in Organ Transplantation 2009;14:426-31. [DOI: 10.1097/mot.0b013e32832c5999] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
130 Alkhouri N, Hanouneh IA, Lopez R, Zein NN. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression. Liver Transpl. 2010;16:155-162. [PMID: 20104483 DOI: 10.1002/lt.21939] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
131 Heikal N, Bader F, Martins T, Pavlov I, Wilson A, Barakat M, Stehlik J, Kfoury A, Gilbert E, Delgado J, Hill H. Immune Function Surveillance: Association With Rejection, Infection and Cardiac Allograft Vasculopathy. Transplantation Proceedings 2013;45:376-82. [DOI: 10.1016/j.transproceed.2012.04.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
132 Miller RJ, Khush KK. Transplant phenomapping: A move toward personalized immunosuppression. The Journal of Heart and Lung Transplantation 2018;37:943-4. [DOI: 10.1016/j.healun.2018.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Fukuda A, Imadome K, Sakamoto S, Shigeta T, Uchida H, Matsunami M, Sasaki K, Kanazawa H, Kawano F, Nakazawa A, Fujiwara S, Kasahara M. Evaluation of the immune function assay in pediatric living donor liver transplantation. Pediatr Transplant 2015;19:144-52. [PMID: 25418834 DOI: 10.1111/petr.12402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
134 Brandhorst G, Weigand S, Eberle C, Raddatz D, Karaus M, Oellerich M, Walson PD. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta. 2013;421:31-33. [PMID: 23485644 DOI: 10.1016/j.cca.2013.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
135 Süsal C, Opelz G. Options for Immunologic Support of Renal Transplantation Through the HLA and Immunology Laboratories. Am J Transplant 2007;7:1450-6. [DOI: 10.1111/j.1600-6143.2007.01824.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
136 Dharnidharka VR, Hesemann LE. The ImmuKnow assay--does it really put us in the know about the immune system? Pediatr Transplant 2014;18:415-6. [PMID: 25041327 DOI: 10.1111/petr.12291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Arias M, Serón D, Moreso F, Bestard O, Praga M. Chronic renal allograft damage: existing challenges. Transplantation 2011;91:S4-25. [PMID: 21519213 DOI: 10.1097/TP.0b013e31821792fd] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
138 Akbari M, Saha MN, Telfer S, Ullah S, Mok A, McAlister V, Juriasingani S, Luke PP, Sener A. Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients. Transplant Proc 2019;51:1744-53. [PMID: 31399162 DOI: 10.1016/j.transproceed.2019.03.024] [Reference Citation Analysis]
139 Yang G, Ou M, Chen H, Guo C, Chen J, Lin H, Tang D, Xue W, Li W, Sui W, Dai Y. Characteristic analysis of TCR β-chain CDR3 repertoire for pre- and post-liver transplantation. Oncotarget 2018;9:34506-19. [PMID: 30349645 DOI: 10.18632/oncotarget.26138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
140 Oura T, Yamashita K, Suzuki T, Fukumori D, Watanabe M, Hirokata G, Wakayama K, Taniguchi M, Shimamura T, Miura T, Okimura K, Maeta K, Haga H, Kubota K, Shimizu A, Sakai F, Furukawa H, Todo S. Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates: ASKP1240 Prevents Hepatic Rejection in NHPs. American Journal of Transplantation 2012;12:1740-54. [DOI: 10.1111/j.1600-6143.2012.04014.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
141 Reinsmoen NL. A new era for T-cell immune function assays in transplantation. Tissue Antigens 2010;75:658-67. [DOI: 10.1111/j.1399-0039.2010.01441.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
142 Uemura T, Riley TR, Khan A, Hollenbeak C, Schreibman I, Ghahramani N, Reeves B, Domen RE, Zander DS, Kadry Z. Immune functional assay for immunosuppressive management in post-transplant malignancy. Clin Transplant 2011;25:E32-7. [PMID: 20636411 DOI: 10.1111/j.1399-0012.2010.01303.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
143 Leung DH, Ton-That M, Economides JM, Healy CM. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients. Am J Transplant. 2015;15:535-540. [PMID: 25611886 DOI: 10.1111/ajt.12987] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
144 Li RD, Sun Z, Dong JY, Yin H, Guo WY, Fu ZR, Wang ZX. A quantitative assessment model of T-cell immune function for predicting risks of infection and rejection during the early stage after liver transplantation. Clin Transplant 2013;27:666-72. [PMID: 23914809 DOI: 10.1111/ctr.12187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Zarrinpar A, Busuttil RW. Immunomodulating options for liver transplant patients. Expert Rev Clin Immunol 2012;8:565-78; quiz 578. [PMID: 22992151 DOI: 10.1586/eci.12.47] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
146 Guillén D, Cofán F, Ros E, Millán O, Cofán M, Brunet M. Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients. Mol Diagn Ther. 2010;14:357-366. [PMID: 21047146 DOI: 10.2165/11539620-000000000-00000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 2021. [PMID: 34510731 DOI: 10.1111/ajt.16835] [Reference Citation Analysis]
148 Sudan D. Long-term outcomes and quality of life after intestine transplantation: . Current Opinion in Organ Transplantation 2010;15:357-60. [DOI: 10.1097/mot.0b013e3283398565] [Cited by in Crossref: 39] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
149 White PC, Chamberlain-Shea H, de la Morena MT. Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation. J Diabetes Complications 2010;24:209-13. [PMID: 19854074 DOI: 10.1016/j.jdiacomp.2009.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
150 Ekong UD, Miller SD, O'Gorman MR. In vitro assays of allosensitization. Pediatr Transplant 2009;13:25-34. [PMID: 19017286 DOI: 10.1111/j.1399-3046.2008.01042.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
151 Daniel V, Opelz G. Clinical Relevance of Immune Monitoring in Solid Organ Transplantation. International Reviews of Immunology 2009;28:155-84. [DOI: 10.1080/08830180902929404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
152 Lo DJ, Kaplan B, Kirk AD. Biomarkers for kidney transplant rejection. Nat Rev Nephrol. 2014;10:215-225. [PMID: 24445740 DOI: 10.1038/nrneph.2013.281] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
153 Millán O, Sánchez-Fueyo A, Rimola A, Guillen D, Hidalgo S, Benitez C, Campistol JM, Brunet M. Is the intracellular ATP concentration of CD4+ T-Cells a predictive biomarker of immune status in stable transplant recipients? Transplantation 2009;88:S78-84. [PMID: 19667966 DOI: 10.1097/TP.0b013e3181afeba6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
154 Rello J. Lung transplant: an emerging challenge in the ICU. Med Intensiva 2012;36:504-5. [PMID: 22858072 DOI: 10.1016/j.medin.2012.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
155 Boleslawski E, BenOthman S, Grabar S, Correia L, Podevin P, Chouzenoux S, Soubrane O, Calmus Y, Conti F. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant. 2008;22:494-501. [PMID: 18565100 DOI: 10.1111/j.1399-0012.2008.00815.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
156 Cabrera R, Ararat M, Soldevila-Pico C, Dixon L, Pan JJ, Firpi R, Machicao V, Levy C, Nelson D, Morelli G. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl. 2009;15:216-222. [PMID: 19177434 DOI: 10.1002/lt.21666] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
157 Martínez-Flores JA, Serrano M, Morales P, Paz-Artal E, Morales JM, Serrano A. Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients. J Immunol Methods 2014;403:62-5. [PMID: 24291342 DOI: 10.1016/j.jim.2013.11.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
158 Li S, Wang W, Hu X, Ren L, Yin H, Yang X, Liu H, Zhang X. The effects of early rapid corticosteroid reduction on cell-mediated immunity in kidney transplant recipients. Transpl Immunol 2011;24:127-30. [PMID: 20888912 DOI: 10.1016/j.trim.2010.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
159 Berglund D, Bengtsson M, Biglarnia A, Berglund E, Yamamoto S, von Zur-Mühlen B, Lorant T, Tufveson G. Screening of mortality in transplant patients using an assay for immune function. Transpl Immunol. 2011;24:246-250. [PMID: 21232600 DOI: 10.1016/j.trim.2010.12.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
160 Fribourg M, Anderson L, Fischman C, Cantarelli C, Perin L, La Manna G, Rahman A, Burrell BE, Heeger PS, Cravedi P. T-cell exhaustion correlates with improved outcomes in kidney transplant recipients. Kidney Int 2019;96:436-49. [PMID: 31040060 DOI: 10.1016/j.kint.2019.01.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
161 Moon HH, Kim TS, Roh YN, Lee S, Song S, Shin M, Kim JM, Hyuck C, Kwon D, Kim SJ, Joh JW, Lee SK. Can immune function assay predict infection or recovery? Transplant Proc 2012;44:1048-51. [PMID: 22564622 DOI: 10.1016/j.transproceed.2012.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
162 Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Legaz I, Muro M, García-Alonso AM, Martínez-Sánchez MV, Moral JM, Pascual-Figal DA, Alvarez-López MR, Miras M, Minguela A. CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation. Hum Immunol 2011;72:841-8. [PMID: 21742001 DOI: 10.1016/j.humimm.2011.06.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
163 Mizuno S, Muraki Y, Nakatani K, Tanemura A, Kuriyama N, Ohsawa I, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Yamada T, Shiraki K, Takei Y, Nobori T, Okuda M, Isaji S. Immunological aspects in late phase of living donor liver transplant patients: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity. Clin Dev Immunol 2013;2013:982163. [PMID: 24187567 DOI: 10.1155/2013/982163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
164 Te HS, Dasgupta KA, Cao D, Satoskar R, Mohanty SR, Reau N, Millis JM, Jensen DM. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant 2012;26:826-32. [DOI: 10.1111/j.1399-0012.2012.01632.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
165 Avery RK. Management of late, recurrent, and resistant cytomegalovirus in transplant patients. Transplantation Reviews 2007;21:65-76. [DOI: 10.1016/j.trre.2007.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
166 Morrissey CO. Unraveling the relationship between rejection and infection. J Heart Lung Transplant 2019;38:1233-4. [PMID: 31311697 DOI: 10.1016/j.healun.2019.06.008] [Reference Citation Analysis]
167 Morelon E, Thaunat O, Kanitakis J. Advances in Diagnosing Skin Rejection and Immune Monitoring. In: Brandacher G, editor. The Science of Reconstructive Transplantation. New York: Springer; 2015. pp. 103-24. [DOI: 10.1007/978-1-4939-2071-6_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Schaub S, Wilkins JA, Rush D, Nickerson P. Developing a tool for noninvasive monitoring of renal allografts. Expert Rev Proteomics 2006;3:497-509. [PMID: 17078764 DOI: 10.1586/14789450.3.5.497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
169 Martínez C, Millán O, Rovira M, Fernández-Avilés F, López A, Suárez-Lledó M, Carreras E, Urbano-Ispízua Á, Brunet M. Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2017;105:497-505. [PMID: 27882485 DOI: 10.1007/s12185-016-2145-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
170 Andrikopoulou E, Mather PJ. Current insights: use of Immuknow in heart transplant recipients. Prog Transplant 2014;24:44-50. [PMID: 24598565 DOI: 10.7182/pit2014664] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
171 Wozniak LJ, Venick RS, Gordon Burroughs S, Ngo KD, Duffy JP, Farmer DG. Utility of an immune cell function assay to differentiate rejection from infectious enteritis in pediatric intestinal transplant recipients. Clin Transplant 2014;28:229-35. [PMID: 24433466 DOI: 10.1111/ctr.12303] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
172 Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant. 2010;24:701-708. [PMID: 20047619 DOI: 10.1111/j.1399-0012.2009.01169.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
173 Gupta S, Mitchell JD, Markham DW, Mammen PP, Patel PC, Kaiser PA, Stastny P, Ring WS, Dimaio JM, Drazner MH. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant 2008;27:817-22. [PMID: 18656792 DOI: 10.1016/j.healun.2008.05.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
174 Huskey J, Gralla J, Wiseman AC. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Clin J Am Soc Nephrol 2011;6:423-9. [PMID: 21088287 DOI: 10.2215/CJN.04210510] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
175 Goulet O, Sauvat F. Intestinal transplantation: current improvements and perspectives. Curr Opin Organ Transplant 2007;12:265-70. [PMID: 27711016 DOI: 10.1097/MOT.0b013e32814a5a3b] [Reference Citation Analysis]
176 Kobashigawa JA, Kiyosaki KK, Patel JK, Kittleson MM, Kubak BM, Davis SN, Kawano MA, Ardehali AA. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. J Heart Lung Transplant 2010;29:504-8. [PMID: 20133166 DOI: 10.1016/j.healun.2009.12.015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
177 Nobuoka Y, Mizuno S, Nishikawa K, Nakatani K, Muraki Y, Yamada T, Okuda M, Nobori T, Sugimura Y, Isaji S. Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay. Clin Dev Immunol 2013;2013:936063. [PMID: 24454479 DOI: 10.1155/2013/936063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
178 Maki K, Takeno S, Aisu N, Yamashita K, Naito M, Hoshino S, Yamashita Y. CD4+ T-lymphocytes are activated by surgical stress following colorectal resection in cancer patients. Mol Clin Oncol 2015;3:79-82. [PMID: 25469274 DOI: 10.3892/mco.2014.442] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Jo Y, Lim J, Kim Y, Han K, Min W, Oh E. CD4 T-cell function assay using Cylex ImmuKnow and lymphocyte subset recovery following allogeneic hematopoietic stem cell transplantation. Transplant Immunology 2015;33:78-83. [DOI: 10.1016/j.trim.2015.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
180 Israeli M, Klein T, Herscovici C, Ram R, Shpilberg O, Sredni B, Yeshurun M. Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay. Clin Exp Immunol 2013;172:475-82. [PMID: 23600836 DOI: 10.1111/cei.12072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
181 Gardiner BJ, Lee SJ, Cristiano Y, Levvey BJ, Sullivan LC, Snell GI, Peleg AY, Westall GP. Evaluation of Quantiferon®-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients. Transpl Infect Dis 2021;23:e13550. [PMID: 33351991 DOI: 10.1111/tid.13550] [Reference Citation Analysis]
182 Monforte V, Ussetti P, Castejón R, Sintes H, Pérez VL, Laporta R, Sole A, Cifrián JM, Marcos PJ, Redel J, Arcos IL, Berastegui C, Alonso R, Rosado S, Escriva J, Iturbe D, Ovalle JP, Vaquero JM, López-Meseguer M, Mendoza A, Gómez-Ollés S. Predictive Value of Immune Cell Functional Assay for Non-Cytomegalovirus Infection in Lung Transplant Recipients: A Multicenter Prospective Observational Study. Arch Bronconeumol (Engl Ed) 2021:S0300-2896(21)00003-X. [PMID: 33551278 DOI: 10.1016/j.arbres.2020.12.024] [Reference Citation Analysis]
183 Xue F, Zhang J, Han L, Li Q, Xu N, Zhou T, Xi Z, Wu Y, Xia Q. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation. 2010;89:620-626. [PMID: 20010326 DOI: 10.1097/tp.0b013e3181c690fa] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
184 Nishikawa K, Mizuno S, Masui S, Kanda H, Yamada Y, Arima K, Isaji S, Sugimura Y. Usefulness of monitoring cell-mediated immunity for predicting post-kidney transplantation viral infection. Transplant Proc. 2014;46:552-555. [PMID: 24656010 DOI: 10.1016/j.transproceed.2013.11.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
185 Moon HH, Kim TS, Lee S, Song S, Shin M, Park JB, Kim JM, Jang HR, Huh W, Joh JW, Kim SJ. Serial ImmuKnow assay in stable kidney transplant recipients. Cent Eur J Immunol 2014;39:96-9. [PMID: 26155107 DOI: 10.5114/ceji.2014.42132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
186 Hopper K, Mehl ML, Kass PH, Kyles A, Gregory CR. Outcome after Renal Transplantation in 26 Dogs: Renal Transplantation in Dogs. Veterinary Surgery 2012. [DOI: 10.1111/j.1532-950x.2011.00924.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
187 Laporta Hernández R, Lázaro Carrasco MT, Varela de Ugarte A, Ussetti Gil P. Seguimiento a largo plazo del paciente trasplantado pulmonar. Archivos de Bronconeumología 2014;50:67-72. [DOI: 10.1016/j.arbres.2013.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
188 Aisu N, Tanimura S, Yamashita Y, Yamashita K, Maki K, Yoshida Y, Sasaki T, Takeno S, Hoshino S. Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer. Exp Ther Med 2015;10:966-72. [PMID: 26622423 DOI: 10.3892/etm.2015.2640] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
189 Cattral M, Luke S, Knauer MJ, Norgate A, Schiff J, Muirhead N, Luke PP. Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patients. Clin Transplant 2018;32:e13180. [DOI: 10.1111/ctr.13180] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
190 Heidt S, San Segundo D, Shankar S, Mittal S, Muthusamy AS, Friend PJ, Fuggle SV, Wood KJ. Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011;92:1-9. [PMID: 21494177 DOI: 10.1097/TP.0b013e318218e978] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
191 He J, Li Y, Zhang H, Wei X, Zheng H, Xu C, Bao X, Yuan X, Hou J. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation. Clin Transplant. 2013;27:E351-E358. [PMID: 23682828 DOI: 10.1111/ctr.12134] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
192 Germani G, Rodriguez-Castro K, Russo FP, Senzolo M, Zanetto A, Ferrarese A, Burra P. Markers of acute rejection and graft acceptance in liver transplantation. World J Gastroenterol 2015; 21(4): 1061-1068 [PMID: 25632178 DOI: 10.3748/wjg.v21.i4.1061] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
193 Cravedi P, Heeger PS. Immunologic monitoring in transplantation revisited. Curr Opin Organ Transplant. 2012;17:26-32. [PMID: 22186089 DOI: 10.1097/mot.0b013e32834ee402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
194 Levitsky J, Asrani SK, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Kandpal M, Bridges N, Brown M, Armstrong B, Kurian S, Demetris AJ, Abecassis M; Clinical Trials in Organ Transplantation - 14 Consortium. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation. Am J Transplant 2020;20:2173-83. [PMID: 32356368 DOI: 10.1111/ajt.15953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
195 Torre-cisneros J, Aguado J, Caston J, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas M, Fernández-ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-medrano F, Manito N, Marcos M, Martín-dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-romero P, Rodriguez-bernot A, Rumbao J, San Juan R, Vaquero J, Vidal E. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplantation Reviews 2016;30:119-43. [DOI: 10.1016/j.trre.2016.04.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
196 Girlanda R, Mannon RB, Kirk AD. Diagnostic Tools for Monitoring Kidney Transplant Recipients. Seminars in Nephrology 2007;27:462-78. [DOI: 10.1016/j.semnephrol.2007.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
197 Beier UH, Kaplan B, Setty S, Samuel S, Mathew AV, Oberholzer J, Benedetti E, John E. Electrolyte imbalances in pediatric living related small bowel transplantation. Transplantation. 2008;85:217-223. [PMID: 18212626 DOI: 10.1097/TP.0b013e31816025b4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
198 Pons JA, Revilla-nuin B, Ramírez P, Baroja-mazo A, Parrilla P. Desarrollo de inmunotolerancia en el trasplante hepático. Gastroenterología y Hepatología 2011;34:155-69. [DOI: 10.1016/j.gastrohep.2010.11.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
199 Xue F, Han L, Chen Y, Xi Z, Li Q, Xu N, Xia Y, Streicher K, Zhang J, Xia Q. CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients. Pediatr Transplantation 2014;18:166-76. [DOI: 10.1111/petr.12216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
200 Peleg AY, Lasalvia MT, Mylonakis E, Silveira FP. Prophylaxis against pulmonary viral and fungal infections in solid organ transplant recipients. Curr Infect Dis Rep 2009;11:209-15. [PMID: 19366563 DOI: 10.1007/s11908-009-0031-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
201 Manga K, Serban G, Schwartz J, Slotky R, Patel N, Fan J, Bai X, Chari A, Savage D, Suciu-Foca N, Colovai AI. Increased adenosine triphosphate production by peripheral blood CD4+ cells in patients with hematologic malignancies treated with stem cell mobilization agents. Hum Immunol 2010;71:652-8. [PMID: 20381567 DOI: 10.1016/j.humimm.2010.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
202 Krenzien F, ElKhal A, Quante M, Rodriguez Cetina Biefer H, Hirofumi U, Gabardi S, Tullius SG. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation. Transplantation 2015;99:2258-68. [PMID: 26244716 DOI: 10.1097/TP.0000000000000842] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 9.2] [Reference Citation Analysis]
203 Libri I, Gnappi E, Zanelli P, Reina M, Giuliodori S, Vaglio A, Palmisano A, Buzio C, Riva G, Barozzi P. Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study. Am J Transplant. 2013;13:3215-3222. [PMID: 24266972 DOI: 10.1111/ajt.12503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
204 Chandrashekaran S, Crow Pharm SA, Shah SZ, Arendt Pharm CJ, Kennedy CC. Immunosuppression for Lung Transplantation: Current and Future. Curr Transplant Rep 2018;5:212-9. [PMID: 30740294 DOI: 10.1007/s40472-018-0199-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
205 Mimuro J, Mizuta K, Kawano Y, Hishikawa S, Hamano A, Kashiwakura Y, Ishiwata A, Ohmori T, Madoiwa S, Kawarasaki H. Impact of acute cellular rejection on coagulation and fibrinolysis biomarkers within the immediate post-operative period in pediatric liver transplantation. Pediatr Transplant. 2010;14:369-376. [PMID: 19793340 DOI: 10.1111/j.1399-3046.2009.01248.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
206 Zeevi A, Lunz J. Cylex ImmuKnow Cell Function Assay. Methods Mol Biol 2013;1034:343-51. [PMID: 23775749 DOI: 10.1007/978-1-62703-493-7_21] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
207 Chiereghin A, Petrisli E, Ravaioli M, Morelli MC, Turello G, Squarzoni D, Piccirilli G, Ambretti S, Gabrielli L, Pinna AD, Landini MP, Lazzarotto T. Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. Med Microbiol Immunol 2017;206:63-71. [PMID: 27783145 DOI: 10.1007/s00430-016-0485-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
208 Zhou H, Wu Z, Ma L, Wu W, Yang S, Wang Q, Yuan X, Wu L, Lin X, Tan J. Assessing immunologic function through CD4 T-lymphocyte ahenosine triphosphate levels by ImmuKnow assay in Chinese patients following renal transplantation. Transplant Proc 2011;43:2574-8. [PMID: 21911125 DOI: 10.1016/j.transproceed.2011.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
209 Kowalski RJ, Zeevi A, Mannon RB, Britz JA, Carruth LM. Immunodiagnostics: Evaluation of Functional T-Cell Immunocompetence in Whole Blood Independent of Circulating Cell Numbers. Journal of Immunotoxicology 2008;4:225-32. [DOI: 10.1080/15476910701385638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
210 Vyas S, Roberti I. Lymphocyte ATP immune cell function assay in pediatric renal transplants: is it useful? Transplant Proc 2011;43:3675-8. [PMID: 22172824 DOI: 10.1016/j.transproceed.2011.08.096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
211 Dharnidharka VR, Gupta S, Al Khasawneh E, Haafiz A, Shuster JJ, Theriaque DW, Shahlaee AH, Garrett TJ. Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: prediction of acute rejection vs. viral replication events. Pediatr Transplant 2011;15:321-8. [PMID: 21492353 DOI: 10.1111/j.1399-3046.2011.01485.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
212 Lawrence KL, White PH, Morris GP, Jennemann J, Phelan DL, Hotchkiss RS, Kollef MH. CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study. Crit Care 2010;14:R110. [PMID: 20540723 DOI: 10.1186/cc9059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
213 Levitsky J, Mathew JM, Abecassis M, Tambur A, Leventhal J, Chandrasekaran D, Herrera N, Al-Saden P, Gallon L, Abdul-Nabi A. Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology. 2013;57:239-248. [PMID: 22234876 DOI: 10.1002/hep.25579] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
214 Venick RS. Grant monitoring after intestinal transplantation. Curr Opin Organ Transplant 2021;26:234-9. [PMID: 33410638 DOI: 10.1097/MOT.0000000000000847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Epailly E, Albanell J, Andreassen A, Bara C, Campistol JM, Delgado JF, Eisen H, Fiane AE, Mohacsi P, Schubert S. Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. Clin Transplant. 2011;25:E475-E486. [PMID: 21592231 DOI: 10.1111/j.1399-0012.2011.01476.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
216 Verhelst XP, Troisi RI, Colle I, Geerts A, van Vlierberghe H. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review. Hepatol Res. 2013;43:165-178. [PMID: 23186289 DOI: 10.1111/hepr.12012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
217 Lipshultz SE, Chandar JJ, Rusconi PG, Fornoni A, Abitbol CL, Burke GW 3rd, Zilleruelo GE, Pham SM, Perez EE, Karnik R, Hunter JA, Dauphin DD, Wilkinson JD. Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) 2014;69 Suppl 1:55-72. [PMID: 24860861 DOI: 10.6061/clinics/2014(sup01)11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Böhmig GA, Wahrmann M, Säemann MD. Detecting adaptive immunity: applications in transplantation monitoring. Mol Diagn Ther 2010;14:1-11. [PMID: 20121285 DOI: 10.1007/BF03256348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
219 Crespo E, Bestard O. Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients. Clin Biochem 2016;49:329-37. [PMID: 26279496 DOI: 10.1016/j.clinbiochem.2015.08.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
220 Choi J, Bano A, Azzi J. Biomarkers in Solid Organ Transplantation. Clin Lab Med 2019;39:73-85. [PMID: 30709510 DOI: 10.1016/j.cll.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
221 Rossano JW, Denfield SW, Kim JJ, Price JF, Jefferies JL, Decker JA, Smith EO, Clunie SK, Towbin JA, Dreyer WJ. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2009;28:26-31. [PMID: 19134527 DOI: 10.1016/j.healun.2008.10.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
222 Gesundheit B, Budowski E, Israeli M, Shapira MY, Resnick IB, Bringer R, Azar Y, Samuel S, Dray L, Amar A, Kristt D, Or R. Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT. Bone Marrow Transplant 2010;45:527-33. [PMID: 19718067 DOI: 10.1038/bmt.2009.182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
223 Smith HJ, Hanvesakul R, Bentall A, Shabir S, Morgan MD, Briggs D, Cockwell P, Borrows R, Larché M, Ball S. T Lymphocyte Responses to Nonpolymorphic HLA-Derived Peptides Are Associated With Chronic Renal Allograft Dysfunction. Transplantation 2011;91:279-86. [DOI: 10.1097/tp.0b013e318203862d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
224 Sigdel TK, Lee S, Sarwal MM. Profiling the proteome in renal transplantation. Proteomics Clin Appl 2011;5:269-80. [PMID: 21520424 DOI: 10.1002/prca.201000117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
225 Myslik F, House AA, Yanko D, Warren J, Caumartin Y, Rehman F, Jevnikar AM, Stitt L, Luke PP. Preoperative Cylex assay predicts rejection risk in patients with kidney transplant. Clin Transplant. 2014;28:606-610. [PMID: 24628326 DOI: 10.1111/ctr.12359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
226 Kittleson MM. New issues in heart transplantation for heart failure. Curr Treat Options Cardiovasc Med 2012;14:356-69. [PMID: 22648352 DOI: 10.1007/s11936-012-0184-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
227 Shipkova M, López OM, Picard N, Noceti O, Sommerer C, Christians U, Wieland E. Analytical Aspects of the Implementation of Biomarkers in Clinical Transplantation. Ther Drug Monit 2016;38 Suppl 1:S80-92. [PMID: 26418704 DOI: 10.1097/FTD.0000000000000230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Dharnidharka VR, Al Khasawneh E, Gupta S, Shuster JJ, Theriaque DW, Shahlaee AH, Garrett TJ. Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection. Transplantation 2013;96:567-72. [PMID: 23823655 DOI: 10.1097/TP.0b013e31829c7cec] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
229 Aliabadi A, Cochrane AB, Zuckermann AO. Current strategies and future trends in immunosuppression after heart transplantation. Curr Opin Organ Transplant. 2012;17:540-545. [PMID: 22941325 DOI: 10.1097/mot.0b013e328358000c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
230 Mehrotra A, Leventhal J, Purroy C, Cravedi P. Monitoring T cell alloreactivity. Transplant Rev (Orlando) 2015;29:53-9. [PMID: 25475045 DOI: 10.1016/j.trre.2014.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
231 Honeyman C, Stark H, Wang HC, Hester J, Issa F, Giele H. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges. J Plast Reconstr Aesthet Surg 2021;74:711-7. [PMID: 33436335 DOI: 10.1016/j.bjps.2020.11.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Akimoto M, Yunoue S, Otsubo H, Yoshitama T, Kodama K, Matsushita K, Suruga Y, Kozako T, Toji S, Hashimoto S, Uozumi K, Matsuda T, Arima N. Assessment of peripheral blood CD4+ adenosine triphosphate activity in patients with rheumatoid arthritis. Modern Rheumatology 2014;23:19-27. [DOI: 10.3109/s10165-012-0621-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
233 Sawitzki B, Schlickeiser S, Reinke P, Volk HD. Pretransplant immune risk assessment. Curr Opin Organ Transplant 2009;14:650-5. [PMID: 19779344 DOI: 10.1097/MOT.0b013e32833281f8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
234 Calarota SA, Aberle JH, Puchhammer-Stöckl E, Baldanti F. Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications. J Clin Virol. 2015;70:109-119. [PMID: 26305832 DOI: 10.1016/j.jcv.2015.07.299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]